Extensive Sequence and Structural Evolution of Inhibitory Antibodies to Arginase2 Enabled by an Unbiased Approach to Affinity Maturation

Posted by

Technology Networks

8 views

|

December 5, 2022

Add to Playlist

Speaking at the Advances in Drug Discovery & Development 2022 online symposium, Stuart Haynes discussed an unbiased approach to affinity maturation via extensive sequence and structural evolution.

Analytical Techniques Biopharma Drug Discovery Next-Generation Sequencing

Up Next

Autoplay

More Videos from Technology Networks

TSE Explores Drug Discovery - Testing a Drug Compound: Preclinical Screening S05E03

Technology Networks

10 months ago

Cancer Research Drug Discovery Imaging/Microscopy Informatics

Generating Highly Multiplexed Immunofluorescence Data and Bridging the Gap Between Research and Conventional Clinical Pathology

Technology Networks

11 months ago

Cell Science Drug Discovery Next-Generation Sequencing Proteomics and Metabolomics

Accessible Single Cell Proteomics by Mass Spectrometry

Technology Networks

11 months ago

Drug Discovery Mass Spectrometry Proteomics and Metabolomics Spectroscopy

Playlists featuring Technology Networks

Advances in Drug Discovery & Developement 2022

Technology Networks

Exploring Psychedelics

Technology Networks

Exploring Infection and Immunity

Technology Networks

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.

Subscribe To Newsletter Image